Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians

Taispeáin leaganacha eile (1)

Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has been published from clinical trials and national epidemiological databases in the last three years. In the United Kingdom Atomoxetine is currently the only licensed non-stimulant medication. As part o...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Chris J. Bushe Mbbs, Nicola Savill
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	SAGE Publishing 2011-01-01
Sraith:	Journal of Central Nervous System Disease
Rochtain ar líne:	https://doi.org/10.4137/JCNSD.S4391

Míreanna comhchosúla

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
de réir: Chris J. Bushe MBBS, et al.
Foilsithe / Cruthaithe: (2011-12-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
de réir: Clemow DB, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
de réir: Paul Hammerness, et al.
Foilsithe / Cruthaithe: (2009-03-01)

A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
de réir: Savill Nicola, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
de réir: Su Jin Moon, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
de réir: Schacht Alexander, et al.
Foilsithe / Cruthaithe: (2010-12-01)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
de réir: Tsutomu Nagai, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
de réir: Rubin Richard, et al.
Foilsithe / Cruthaithe: (2009-12-01)

Effect of sluggish cognitive tempo on the efficacy of atomoxetine in children with attention-deficit/hyperactivity disorder
de réir: Wenjun WU, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
de réir: Vijaya Kumar, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
de réir: Joseph A, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
de réir: Reimherr Fred, et al.
Foilsithe / Cruthaithe: (2005-10-01)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
de réir: Cao P, et al.
Foilsithe / Cruthaithe: (2018-11-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
de réir: Serkan Turan, et al.
Foilsithe / Cruthaithe: (2019-10-01)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
de réir: Ball Susan, et al.
Foilsithe / Cruthaithe: (2007-09-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
de réir: Dilla Tatiana, et al.
Foilsithe / Cruthaithe: (2009-04-01)

Attention-deficit/hyperactive disorder updates
de réir: Miriam Kessi, et al.
Foilsithe / Cruthaithe: (2022-09-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
de réir: S King, et al.
Foilsithe / Cruthaithe: (2006-07-01)

An updated review on animal models to study attention-deficit hyperactivity disorder
de réir: Daegeon Kim, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Serotonin syndrome induced by overdose of atomoxetine alone in a patient with attention‐deficit hyperactivity disorder: A case report
de réir: Fumika Sato, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting
de réir: Ying Zhang, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
de réir: Satoshi Kasahara, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
de réir: Snircova E., et al.
Foilsithe / Cruthaithe: (2012-12-01)

Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine
de réir: Satoshi Kasahara, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
de réir: Imagawa H, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study
de réir: Huiya Mei, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
de réir: Wilfried Pott, et al.
Foilsithe / Cruthaithe: (2013-03-01)

Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians
de réir: Theodore Petti, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
de réir: Satoshi Kasahara, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
de réir: Turgay Atilla, et al.
Foilsithe / Cruthaithe: (2011-05-01)

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy
de réir: Jeff Schein, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3–6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study
de réir: Hamza A. Alsayouf, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates
de réir: Tae Hoon Eom, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
de réir: Johnston Josephine, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
de réir: Katya Rubia, et al.
Foilsithe / Cruthaithe: (2021-08-01)

A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
de réir: Yuyang Luo, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
de réir: Jadwiga Najib, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Attention deficit hyperactivity disorder.
de réir: Ramchandani, P, et al.
Foilsithe / Cruthaithe: (2003)

Attention deficit/hyperactivity disorder /
de réir: Dudley, William, 1964-
Foilsithe / Cruthaithe: (2005)

Attention-deficit/hyperactivity disorder
de réir: A. M.E. du Plessis
Foilsithe / Cruthaithe: (2015-05-01)